Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis
Objective To identify whether thymosin-α-1 (Tα1) is effective in patients with Coronavirus disease 2019 (COVID-19) and to determine a suitable population for Tα1 treatment. Methods We included studies with ≥10 cases and adults (aged ≥18 years) with laboratory-confirmed SARS-CoV-2 infection, data on...
Main Authors: | Pu Wang, Changhong Wang, Da Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-08-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X231197922 |
Similar Items
-
Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
by: Zhang Daquan, et al.
Published: (2023-02-01) -
Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV
by: Chaoyu Chen, et al.
Published: (2024-01-01) -
INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS
by: I. A. KOROLEVA, et al.
Published: (2017-06-01) -
Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application
by: Nana Tao, et al.
Published: (2023-04-01) -
Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma
by: W. Theunissen, et al.
Published: (2014-03-01)